skip to Main Content

Humana Pharmacy Policy Updates – May 2018

Click here to view the Humana Pharmacy Policy Updates »

May 2018 Pharmacy Policy Updates:

  • Actemra® (tocilizumab) Intravenous
  • Adcirca® (tadalafil)
  • Afinitor® (everolimus)/Afinitor Disperz® (everolimus tablets for oral suspension)
  • Asthma Interleukin Inhibitors (Cinqair, Nucala, Fasenra)
  • Austedo™ (deutetrabenazine)
  • Avastin® (bevacizumab)
  • BPH Agents
  • Banzel® (rufinamide)
  • Byvalson™ (nebivolol and valsartan)
  • Coagadex® (Coagulation Factor X [Human])
  • Corifact® (Factor XIII Concentrate [Human])
  • Cotellic® (cobimetinib)
  • Cycloset® (bromocriptine)
  • Differin® (adapalene) and Epiduo® (adapalene and benzoyl peroxide)
  • Doxil® (doxorubicin liposomal)
  • Epipen® (epinephrine)
  • Exjade® (deferasirox)
  • FEIBA NF (Anti-Inhibitor Coagulant Complex)
  • Farydak® (panobinostat)
  • FazaClo® (clozapine orally disintegrating tablet) and Versacloz® (clozapine oral solution)
  • Ferriprox® (deferiprone)
  • Gattex® (teduglutide)
  • Gralise® (gabapentin)
  • Horizant (gabapentin enacarbil)
  • Ibrance® (palbociclib)
  • Invega® (paliperidone extended release)
  • Jadenu (deferasirox)
  • Keppra XR® (levetiracetam extended release)
  • Kevzara® (sarilumab)
  • Kisqali® (ribociclib)
  • Kyprolis® (carfilzomib)
  • Lamictal ODT® (lamotrigine)
  • Lenvima® (lenvatinib)
  • Lidocaine 5% topical ointment
  • Nerlynx (neratinib)
  • Nexavar® (sorafenib)
  • NovoSeven® RT (Coagulation Factor VIIa [Recombinant])
  • Nuplazid™ (pimavanserin)
  • Obesity Medications
  • Obizur [antihemophilic (recombinant), porcine sequence]
  • Onfi® (clobazam)
  • Oral Acne Antibiotics
  • Orencia® (abatacept) Intravenous
  • Orencia® (abatacept) Subcutaneous
  • Orencia® (abatacept) intravenous solution
  • Oxtellar XR® (oxcarbazepine, extended release)
  • Pancreatic Enzymes
  • Prevpac® (amoxicillin, clarithromycin, lansoprazole)
  • Qutenza® (capsaicin) 8% patch
  • Rayos® (prednisone delayed-release)
  • Revatio® (sildenafil citrate) (intravenous)
  • Revatio® (sildenafil citrate) (oral suspension)
  • Revatio® (sildenafil citrate) (tablet)
  • Rexulti® (brexpiprazole)
  • Rhopressa® (netarsudil)
  • Rubraca® (rucaparib)
  • Ruconest® (C1 esterase inhibitor [recombinant])
  • Rydapt® (midostaurin)
  • Saphris® (asenapine)
  • Tagrisso™ (osimertinib)
  • Thrombate III® [Antithrombin III (Human)]
  • Topical Acne Products
  • Topical Retinoid Products
  • Tretten® (Coagulation Factor XIII A-Subunit [Recombinant])
  • Trogarzo™ (ibalizumab-uiyk)
  • Valstar® (valrubicin)
  • Von Willebrand Factor Replacement Products
  • Xeloda® (capecitabine)
  • Xenical® (orlistat)
  • Xifaxan® (rifaximin)
  • Zevalin® (ibritumomab)
  • Zyclara® (imiquimod)
  • Zydelig® (idelalisib)
  • ADHD Long Acting Stimulants
  • Trintellix (vortioxetine)

Click here to view the Humana Pharmacy Policy Updates »


Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top